Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Monoclonal Gammopathy
100%
Multiple Sclerosis
100%
Interferon beta-1a
100%
Scleromyxedema
100%
Monoclonal Antibody
33%
Skin Lesions
33%
Neurological Manifestations
33%
Neurological Diseases
16%
Potential Therapeutics
16%
Interferon-α (IFN-α)
16%
Older Women
16%
Myelin Repair
16%
Dermatological Diseases
16%
Intravenous Immunoglobulin (IVIg)
16%
No Recurrence
16%
Interferon Therapy
16%
Therapeutic Role
16%
Cutaneous Reaction
16%
Multiple Sclerosis Diagnosis
16%
Demyelinating Disease
16%
Cutaneous Side Effects
16%
Medicine and Dentistry
Monoclonal Gammopathy of Undetermined Significance
100%
Multiple Sclerosis
100%
Lichen Myxedematosus
100%
Beta1a Interferon
100%
Neurologic Disease
50%
Interferon
33%
Human Monoclonal Antibody
33%
Skin Defect
33%
Recurrent Disease
16%
Skin Manifestation
16%
Myelin Repair
16%
Dermatological Agent
16%
Clinically Isolated Syndrome
16%
Intravenous Immunoglobulin Therapy
16%
Diagnosis of Multiple Sclerosis
16%
Diseases
16%
Side Effect
16%